Clinical Trials Logo
  1. Home
  2. Ventricular Dysfunction
  3. NCT00213902

Clonidine and Left Ventricular Dysfunction

Ventricular Dysfunction Clinical Trial

Official title:
Evaluation of Effects of Central Sympathetic Inhibition in Elderly With Left Ventricular Diastolic Dysfunction and Preserved Ejection Fraction: A Proof-of-Concept Trial With Clonidine

Clinical Trial Summary

The objectives of this study are:

1. To evaluate the effect of clonidine, a sympathetic modulator, to reverse cardiac remodeling and to improve hemodynamics in diastolic heart failure (DHF).

2. To evaluate the effect of clonidine on neurohormones and quality of life in patients with DHF.

The study is a double-blind, placebo-controlled study evaluating the effects of clonidine compared to placebo in patients with DHF. A total of 70 patients with DHF will be randomized in a 1:1 ratio to:

1. placebo (n=35) or to

2. clonidine (n=35) in a dose of 0.075 mg twice a day for the first 6 weeks followed by uptitration to 0.150 mg twice a day for 6 months.

The primary outcome is the reversion of cardiac remodeling and hemodynamic parameters evaluated by magnetic resonance imaging (MRI) and echocardiography.

Clinical Trial Description

n/a

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00213902
Study type Observational
Source University Hospital, Strasbourg, France
Contact
Status Withdrawn
Phase Phase 2
Start date April 2004
View Details
See also
  Status Clinical Trial Phase
Completed NCT03799133 - Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery N/A
Not yet recruiting NCT02784912 - Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation N/A
Completed NCT01673230 - Hemodynamic Indices Predictive of a Beneficial Response to Fluid Expansion in Case of Hemodynamic Failure After Cardiac Surgery With Altered Preoperative Ejection Fraction (LVEF≤45%) N/A
Completed NCT00982397 - Safety and Clinical Performance of the Protecta ICD and CRT-D N/A
Completed NCT00187252 - Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity Therapy N/A
Recruiting NCT04848844 - The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
Recruiting NCT05851053 - Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
Recruiting NCT02644850 - Comparison of Gated Blood-pool SPECT and Echocardiogram for Ventricular Function N/A
Completed NCT00526162 - ConsultaTM CRT-D Clinical Evaluation Study N/A
Terminated NCT00524862 - Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death N/A
Withdrawn NCT00166010 - Effects of Nesiritide in Pediatric Patients With Heart Failure N/A
Completed NCT00370643 - Glucose Control in Open Heart Surgery Phase 1
Not yet recruiting NCT04068116 - Impact of Ischemic Post-conditioning N/A
Enrolling by invitation NCT03701997 - Registry to Monitor Berlin Heart EXCOR® Pediatric VAD as a Bridge to Cardiac Transplantation.
Completed NCT02497950 - HeartMate 3 ELEVATE™ Registry
Recruiting NCT05934071 - Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.
Recruiting NCT02816047 - Austrian Wearable Cardioverter Defibrillator Registry
Completed NCT04634708 - The Use of the EXCOR Active Driving Unit for Mobilization of Pediatric Patients With Ventricular Assist Device Support
Terminated NCT02820441 - Benefit of One Month Zopiclone Intake on Adaptative Servoventilation Compliance Phase 4
Completed NCT00893360 - CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction Phase 1